{ "cik": 1314052, "cik_padded": "0001314052", "entityName": "ANAVEX LIFE SCIENCES CORP.", "fiscal_years": [ { "accn": "0001731122-25-001596", "filed": "2025-11-25", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 102577000.0, "eps_diluted": -0.54, "net_income": -46377000.0, "operating_cash_flow": -39044000.0, "operating_income": -51408000.0, "stockholders_equity": 94869000.0, "total_assets": 103815000.0, "total_liabilities": 8946000.0 }, "period_end": "2025-09-30", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.09429845365714828, "roa_avg2y": -0.387472742311452, "roa_period_end": -0.44672735153879495, "roe_avg2y": -0.43114924790361264, "roe_period_end": -0.48885304999525664 } }, { "accn": "0001731122-25-001596", "filed": "2025-11-25", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 132187000.0, "eps_diluted": -0.52, "net_income": -43002000.0, "operating_cash_flow": -30812000.0, "operating_income": -52877000.0, "stockholders_equity": 120263000.0, "total_assets": 135567000.0, "total_liabilities": 15304000.0 }, "period_end": "2024-09-30", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1272544340320797, "roa_avg2y": -0.29661358909892294, "roa_period_end": -0.3172010887605391, "roe_avg2y": -0.3281155218129447, "roe_period_end": -0.3575663337851209 } }, { "accn": "0001731122-25-001596", "filed": "2025-11-25", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 151024000.0, "eps_diluted": -0.6, "net_income": -47505000.0, "operating_cash_flow": -27785000.0, "operating_income": -55763000.0, "stockholders_equity": 141852000.0, "total_assets": 154386000.0, "total_liabilities": 12534000.0 }, "period_end": "2023-09-30", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.0883596988410456, "roa_avg2y": -0.30938711977882777, "roa_period_end": -0.30770277097664295, "roe_avg2y": -0.3341386986843355, "roe_period_end": -0.33489129515269433 } }, { "accn": "0001731122-25-001596", "filed": "2025-11-25", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 149158000.0, "eps_diluted": -0.62, "net_income": -47978000.0, "operating_cash_flow": -24238000.0, "operating_income": -50986000.0, "stockholders_equity": 142491000.0, "total_assets": 152705000.0, "total_liabilities": 10214000.0 }, "period_end": "2022-09-30", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.07168172024899819, "roa_avg2y": -0.3052797949004378, "roa_period_end": -0.31418748567499427, "roe_avg2y": -0.3271509812211055, "roe_period_end": -0.33670898512888525 } }, { "accn": "0001731122-23-002197", "filed": "2023-11-27", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 152107745.0, "eps_diluted": -0.54, "net_income": -37909000.0, "operating_cash_flow": -30384000.0, "operating_income": -42002000.0, "stockholders_equity": 150817000.0, "total_assets": 161616490.0, "total_liabilities": 10798386.0 }, "period_end": "2021-09-30", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.07159926268258883, "roa_avg2y": -0.3865135985540115, "roa_period_end": -0.23456146090043167, "roe_avg2y": -0.42581464050231954, "roe_period_end": -0.25135760557496833 } }, { "accn": "0001731122-23-002197", "filed": "2023-11-27", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 29249018.0, "net_income": -26280470.0, "operating_cash_flow": -21287046.0, "operating_income": -31088232.0, "stockholders_equity": 27237000.0, "total_assets": 34542197.0, "total_liabilities": 7305628.0 }, "period_end": "2020-09-30", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.26822440063149394, "roa_avg2y": -0.8778948004871093, "roa_period_end": -0.760822190898859, "roe_avg2y": -1.1059244825734689, "roe_period_end": -0.964881227741675 } }, { "accn": "0001731122-22-002062", "filed": "2022-11-28", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 22185630.0, "net_income": -26294979.0, "operating_cash_flow": -18527117.0, "stockholders_equity": 20289699.0, "total_assets": 25329373.0, "total_liabilities": 5039674.0 }, "period_end": "2019-09-30", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.24838584347653456, "roa_avg2y": -1.0204569473643461, "roa_period_end": -1.0381219858857145, "roe_avg2y": -1.2341759287627172, "roe_period_end": -1.295976790981473 } }, { "accn": "0001731122-20-001338", "filed": "2020-12-28", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "cash": 22930638.0, "net_income": -17252736.0, "operating_cash_flow": -12582406.0, "stockholders_equity": 22321696.0, "total_assets": 26206322.0 }, "period_end": "2018-09-30", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "roa_avg2y": -0.6384622966665101, "roa_period_end": -0.6583425175039824, "roe_avg2y": -0.7158038787679438, "roe_period_end": -0.7729133126801835 } }, { "accn": "0001731122-19-000784", "filed": "2019-12-16", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 27440257.0, "net_income": -13460405.0, "operating_cash_flow": -9017231.0, "stockholders_equity": 25883508.0, "total_assets": 27838329.0, "total_liabilities": 3584334.0 }, "period_end": "2017-09-30", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.13847945185791663, "roa_avg2y": -0.721022117196851, "roa_period_end": -0.48352058056358194, "roe_avg2y": -0.8362664943321974, "roe_period_end": -0.5200378943997854 } }, { "accn": "0001615774-19-001031", "filed": "2019-01-25", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 9186814.0, "eps_diluted": -0.42, "net_income": -14736698.0, "operating_cash_flow": -9236823.0, "stockholders_equity": 6308156.0, "total_assets": 9498681.0, "total_liabilities": 3190525.0 }, "period_end": "2016-09-30", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5057777581911418, "roa_period_end": -1.5514467745574358, "roe_period_end": -2.3361340461459736 } }, { "accn": "0001615774-16-008914", "filed": "2016-12-14", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares", "total_liabilities": "USD" }, "fundamentals": { "eps_diluted": -0.65, "total_liabilities": 2660910.0 }, "period_end": "2015-09-30", "ratios": {} }, { "accn": "0001615774-16-008914", "filed": "2016-12-14", "fiscal_year": 2014, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares", "operating_income": "USD" }, "fundamentals": { "eps_diluted": -1.02, "operating_income": -2968975.0 }, "period_end": "2014-09-30", "ratios": {} }, { "accn": "0001062993-14-007294", "filed": "2014-12-29", "fiscal_year": 2013, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares", "operating_income": "USD" }, "fundamentals": { "eps_diluted": -0.12, "operating_income": -2137367.0 }, "period_end": "2013-09-30", "ratios": {} }, { "accn": "0001062993-13-006497", "filed": "2013-12-30", "fiscal_year": 2012, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares", "operating_income": "USD" }, "fundamentals": { "eps_diluted": -0.29, "operating_income": -4321491.0 }, "period_end": "2012-09-30", "ratios": {} }, { "accn": "0001062993-12-005603", "filed": "2012-12-31", "fiscal_year": 2011, "form": "10-K", "fundamental_units": { "operating_income": "USD" }, "fundamentals": { "operating_income": -6180582.0 }, "period_end": "2011-09-30", "ratios": {} } ], "latest_filing": { "accn": "0001731122-25-001596", "filed": "2025-11-25", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001314052.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001314052.json" }, "ticker": "AVXL" }